The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5382-5390

  Wu, Shaoguang ^a   Shin, Jai ^a   Zhang, Guangming ^a   Cohen, Mitchell ^b   Franco, Augusto ^a   Sears, Cynthia L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CADHERIN; CELL RECEPTOR; MEMBRANE PROTEIN; METALLOPROTEINASE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; BINDING AFFINITY; CELL MEMBRANE PERMEABILITY; CELL POLARITY; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; LIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

BACTERIAL TOXINS; CADHERINS; CELLS, CULTURED; CHOLESTEROL; DIPEPTIDES; HUMANS; INTESTINAL MUCOSA; MEMBRANE MICRODOMAINS; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECEPTORS, PROTEINASE-ACTIVATED;

EID: 33748050136     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00060-06     Document Type: Article

References (34)

1. Barrett, K. E. 1993. Positive and negative regulation of chloride secretion in T84 cells. Am. J. Physiol. 265:C859-C868.
2. Basset, C., J. Holton, A. Bazeos, D. Vaira, and S. Bloom. 2004. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49:1425-1432.
3. Chamhers, F. G., S. S. Koshy, R. F. Saldi, D. P. Clark, R. D. Moore, and C. L. Sears. 1997. Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect. Immun. 65:3561-3570.
4. Danielsen, E. M., and G. H. Hansen. 2003. Lipid rafts in epithelial brush borders: atypical membrane microdomains with specialized functions. Biochim. Biophys. Acta 1617:1-9.
5. Darmoul, D., J. C. Marie, H. Devaud, V. Gratio, and M. Laburthe. 2001. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br. J. Cancer 85:772-779.
6. Franco, A. A. 2004. The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon. J. Bacteriol. 186:6077-6092.
7. Franco, A. A., S. Buckwold, J. W. Shin, M. Ascon, and C. L. Sears. 2005. Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity without affecting propeptide processing. Infect. Immun. 73:5273-5277.
8. Franco, A. A., R. K. Cheng, A. Goodman, and C. L. Sears. 2002. Modulation of bft expression by the Bacteroides fragilis pathogenicity island and its flanking region. Mol. Microbiol. 45:1067-1077.
9. Huet, C., C. Sahuquillo-Merino, E. Coudrier, and D. Louvard. 1987. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT29) provide new models for cell polarity and terminal differentiation. J. Cell Biol. 105:345-357.
10. Keusch, G. T., and M. Jacewicz. 1977. Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving beta1 leads to 4-linked N-acetyl-D-glucosamine oligomers. J. Exp. Med. 146:535-546.
11. Kim, J. M., Y. K. Oh, Y. J. Kim, H. B. Oh, and Y. J. Cho. 2001. Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression. Clin. Exp. Immunol. 123:421-427.
12. Koon, H. W., D. Zhao, X. Na, M. P. Moyer, and C. Pothoulakis. 2004. Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J. Biol. Chem. 279:45519-45527.
13. Montecucco, C., O. Rossetto, and G. Schiavo. 2004. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 12:442-446.
14. Mundy, L. M., and C. L. Sears. 1996. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Clin. Infect. Dis. 23:269-276.
15. Nathke, I. S., L. Hinck, J. R. Swedlow, J. Papkoff, and W. J. Nelson. 1994. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J. Cell Biol. 125:1341-1352.
16. Obiso, R. J., Jr., A. O. Azghani, and T. D. Wilkins. 1997. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65:1431-1439.
17. Onderdonk, A. B., R. L. Cisneros, R. Finberg, J. H. Crabb, and D. L. Kasper. 1990. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev. Infect. Dis. 12(Suppl. 2):S169-S177.
18. Polk, B. F., and D. L. Kasper. 1977. Bacteroides fragilis subspecies in clinical isolates. Ann. Intern. Med. 86:569-571.
19. Prasadarao, N. V., C. A. Wass, and K. S. Kim. 1996. Endothelial cell GlcNAcβ1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect. Immun. 64:154-160.
20. Prindiville, T. P., R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva, Jr. 2000. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6:171-174.
21. Redondo, M. C., M. D. Arbo, J. Grindlinger, and D. R. Snydman. 1995. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin. Infect. Dis. 20:1492-1496.
22. Riegler, M., M. Lotz, C. Sears, C. Pothoulakis, I. Castagliuolo, C. C. Wang, R. Sedivy, T. Sogukoglu, E. Cosentini, G. Bischof, W. Feil, B. Teleky, G. Hamilton, J. T. LaMont, and E. Wenzl. 1999. Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut 44:504-510.
23. 1) in vitro. Infect. Immun. 64:5029-5034.
24. Sanfilippo, L., C. K. Li, R. Seth, T. J. Balwin, M. G. Menozzi, and Y. R. Mahida. 2000. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells. Clin. Exp. Immunol. 119:456-463.
25. Scobie, H. M., and J. A. Young. 2005. Interactions between anthrax toxin receptors and protective antigen. Curr. Opin. Microbiol. 8:106-112.
26. Sears, C. L. 2001. The toxins of Bacteroides fragilis. Toxicon 39:1737-1746.
27. Sears, C. L., and J. B. Kaper. 1996. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60:167-215.
28. Turton, K., J. A. Chaddock, and K. R. Acharya. 2002. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27:552-558.
29. Vergnolle, N. 2005. Clinical relevance of proteinase activated receptors (PARs) in the gut. Gut 54:867-874.
30. Wu, S., L. A. Dreyfus, A. O. Tzianabos, C. Hayashi, and C. L. Sears. 2002. Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis. Infect. Immun. 70:2463-2471.
31. Wu, S., K.-C. Lim, J. Huang, R. F. Saidi, and C. L. Sears. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95:14979-14984.
32. Wu, S., P. J. Morin, D. Maouyo, and C. L. Sears. 2003. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124:392-400.
33. Wu, S., J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears. 2004. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway. Infect. Immun. 72:5832-5839.
34. Zhang, G., B. Svenungsson, A. Karnell, and A. Weintraub. 1999. Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. Clin. Infect. Dis. 29:590-594.